Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000172

Chairperson & CEO sold 9,500 shares at an average $588.64 ($5,592,095)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-26 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-26 Sale : show line 2 in the form 10b5-1 −600 $585.71 $351,427 333,343 I
2026-10-26 Sale : show line 3 in the form 10b5-1 −1,492 $586.54 $875,124 331,851 I
2026-10-26 Sale : show line 4 in the form 10b5-1 −2,707 $587.54 $1,590,474 329,144 I
2026-10-26 Sale : show line 5 in the form 10b5-1 −1,241 $588.47 $730,285 327,903 I
2026-10-26 Sale : show line 6 in the form 10b5-1 −1,280 $589.64 $754,736 326,623 I
2026-10-26 Sale : show line 7 in the form 10b5-1 −680 $590.57 $401,585 325,943 I
2026-10-26 Sale : show line 8 in the form 10b5-1 −694 $591.60 $410,570 325,249 I
2026-10-26 Sale : show line 9 in the form 10b5-1 −806 $592.92 $477,891 324,443 I
Open-market sales · 9,500 sh · avg $588.64 · $5,592,095

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-26 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option −9,500 157,410 I
Loading xslF345X06/primarydocument.xml…